Alucent Biomedical: Clinical Trials

5 trials sponsored by Alucent Biomedical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed, 1 unknown. 3 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Active not recruiting 2, Unknown 1
Phase 12Completed 2

Follow Alucent Biomedical: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alucent Vessel Restoration System for AVF
Alucent Vessel Restoration System for AVF - AV Fistula
Not applicableUnknownAlucent Biomedical302022-07-152024-03-13
Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II
Vessel Restoration System (VRS) - PAD - Peripheral Arterial Disease
Not applicableActive not recruitingAlucent Biomedical502021-11-152024-01-16
Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I
Vessel Restoration System (VRS) - PAD - Peripheral Arterial Disease
Not applicableActive not recruitingAlucent Biomedical502021-11-152024-01-16
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
NVS Therapy - Peripheral Arterial Disease, Peripheral Vascular Diseases
Phase 1CompletedAlucent Biomedical92020-05-222022-07-14
Natural Vascular Scaffold (NVS) Therapy
NVS Therapy - Peripheral Arterial Disease, Peripheral Vascular Diseases
Phase 1CompletedAlucent Biomedical32017-05-252018-11-14

Conditions studied

Peripheral Arterial Disease (2)  ·  Peripheral Vascular Diseases (2)  ·  Arteriovenous Fistula (1)

Countries

Australia (3)  ·  United States (2)  ·  Poland (1)

Top investigators

Gary Ansel, MD (1)  ·  Henry Hauser (1)